Illumina price target raised to $105 from $100 at BofA

BofA raised the firm’s price target on Illumina to $105 from $100 and keeps an Underperform rating on the shares. Illumina reported Q4 results largely in-line with its preliminary release on January 9, but its formal guidance shows FY24 to be “another challenging year,” the analyst tells investors. Even with the GRAIL drag gone, the margin trajectory unclear, the analyst added.